1. Home
  2. AADI vs MLGO Comparison

AADI vs MLGO Comparison

Compare AADI & MLGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AADI
  • MLGO
  • Stock Information
  • Founded
  • AADI 2011
  • MLGO 2018
  • Country
  • AADI United States
  • MLGO China
  • Employees
  • AADI N/A
  • MLGO N/A
  • Industry
  • AADI Biotechnology: Pharmaceutical Preparations
  • MLGO EDP Services
  • Sector
  • AADI Health Care
  • MLGO Technology
  • Exchange
  • AADI Nasdaq
  • MLGO Nasdaq
  • Market Cap
  • AADI 33.6M
  • MLGO 33.7M
  • IPO Year
  • AADI N/A
  • MLGO N/A
  • Fundamental
  • Price
  • AADI $1.66
  • MLGO $2.84
  • Analyst Decision
  • AADI Buy
  • MLGO
  • Analyst Count
  • AADI 2
  • MLGO 0
  • Target Price
  • AADI $5.00
  • MLGO N/A
  • AVG Volume (30 Days)
  • AADI 329.3K
  • MLGO 15.3M
  • Earning Date
  • AADI 08-07-2024
  • MLGO 08-07-2024
  • Dividend Yield
  • AADI N/A
  • MLGO N/A
  • EPS Growth
  • AADI N/A
  • MLGO N/A
  • EPS
  • AADI N/A
  • MLGO N/A
  • Revenue
  • AADI $23,840,000.00
  • MLGO $580,016,414.00
  • Revenue This Year
  • AADI $4.21
  • MLGO N/A
  • Revenue Next Year
  • AADI $8.61
  • MLGO N/A
  • P/E Ratio
  • AADI N/A
  • MLGO N/A
  • Revenue Growth
  • AADI 26.97
  • MLGO N/A
  • 52 Week Low
  • AADI $1.28
  • MLGO $1.56
  • 52 Week High
  • AADI $7.24
  • MLGO $156.00
  • Technical
  • Relative Strength Index (RSI)
  • AADI 55.23
  • MLGO 37.75
  • Support Level
  • AADI $1.46
  • MLGO $3.80
  • Resistance Level
  • AADI $1.42
  • MLGO $5.86
  • Average True Range (ATR)
  • AADI 0.11
  • MLGO 3.17
  • MACD
  • AADI 0.03
  • MLGO -1.18
  • Stochastic Oscillator
  • AADI 90.48
  • MLGO 0.26

About AADI Aadi Bioscience Inc.

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

About MLGO MicroAlgo Inc.

MicroAlgo Inc is divided into two segments Central processing algorithm services & Intelligent chips and services. The majority is from the Central processing algorithm services. which refer to a range of computing algorithms, analytical algorithms, recommendation algorithms, & acceleration algorithms. The businesses engaged in internet advertisement, game development, intelligent chip design, finance, retail, & logistics depend on the ability to process & analyze data with optimized computing software & hardware capable of handling the data workload. Intelligent chips and services revenues include revenues generated from the resale of intelligent chips. All of the Company's net revenues were generated in the PRC, Hong Kong, & Singapore, out of which the majority is from the PRC.

Share on Social Networks: